Last edition
News about Global Pharma
Sun Pharma Launches Novel Drug in India for Treatment of Erosive Esophagitis
Sun Pharmaceutical Industries Ltd. has launched FEXUCLUE (Fexuprazan 40 mg), a novel treatment for Erosive Esophagitis, in India under a licensing agreement with Korea’s Daewoong Pharmaceutical.
Global Pharma | 07/04/2025 | By Manvi | 504
The Nelipak® medical packaging product lineup includes a comprehensive range of custom designed sterile-barrier packaging solutions.
Global Pharma | 07/04/2025 | By Aishwarya | 325
Amneal Launches BORUZU for Multiple Myeloma and Mantle Cell Lymphoma
BORUZU™ (bortezomib injection), a proteasome inhibitor, is used for the treatment of multiple myeloma and mantle cell lymphoma.
Global Pharma | 07/04/2025 | By Aishwarya | 274
Centrient Pharmaceuticals Join Hands with Computer Shiksha to Transform Education in Punjab
By addressing the lack of digital education resources in these schools, the partnership between Centrient Pharmaceuticals and Computer Shiksha is paving the way for a more inclusive and digitally empowered society.
Global Pharma | 07/04/2025 | By Aishwarya | 195
Glenmark Appoints Anurag Mantri as President
Mantri brings over 30 years of leadership experience across corporate finance, IPOs, M&A, and global compliance.
Global Pharma | 07/04/2025 | By Aishwarya | 271
UPLIZNA Becomes First and Only FDA-Approved Therapy for IGG4-Related Disease
The FDA granted Breakthrough Therapy Designation to UPLIZNA for the treatment of IgG4-RD, recognising the high unmet medical need in this serious condition and the medicine's potential to benefit patients.
Global Pharma | 05/04/2025 | By Abha | 407
Dr. Sanjay Keswani to Lead Medical Strategy at Neurocrine Biosciences as New CMO
Dr. Keswani, who has more than 20 years of pharmaceutical industry experience with broad R&D expertise in multiple therapeutic areas, will lead the clinical development and medical affairs activities at Neurocrine.
Global Pharma | 05/04/2025 | By Abha | 384
DHL Group Acquires CRYOPDP from Cryoport to Boost DHL Health Logistics
Going forward, DHL Supply Chain will further build the potential of its Pharma Specialized Network solution by leveraging the specialty courier expertise of newly acquired CRYOPDP and the global air capabilities of DHL Express and DHL Global Forwarding.
Global Pharma | 05/04/2025 | By Aishwarya | 314
Novartis Completes Acquisition of Anthos Therapeutics for Up to USD 3.1 Billion
Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialise abelacimab.
Global Pharma | 04/04/2025 | By Abha | 700
Sai Life Sciences Establishes Peptide Research Centre in Hyderabad
Sai Life Sciences has inaugurated a state-of-the-art Peptide Research Centre at its Hyderabad R&D campus, expanding its capabilities in complex peptide synthesis and conjugation to support next-generation therapeutics.
Global Pharma | 04/04/2025 | By Abha | 310
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy